Clinical Trials Browser

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma

Glioblastoma, Gliosarcoma

Astrocytoma, Glioblastoma, Glioma

Astrocytoma, Glioblastoma

Brain Neoplasms, Glioblastoma, Glioma, Gliosarcoma

Glioblastoma

Glioblastoma

Astrocytoma, Glioblastoma, Lymphoma, Follicular

Brain Neoplasms, Glioblastoma, Glioma, Neoplasms, Neoplasms by Histologic Type, Neoplasms, Nerve Tissue, Recurrence, Central Nervous System Neoplasms

Glioblastoma, Gliosarcoma

Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Recurrence

Astrocytoma, Glioblastoma, Glioma

Astrocytoma, Brain Neoplasms, Glioblastoma, Recurrence, Gliosarcoma

Glioblastoma, Glioma, Cholangiocarcinoma

Glioblastoma, Gliosarcoma

Glioblastoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Gliosarcoma

Fallopian Tube Neoplasms, Glioblastoma, Ovarian Neoplasms

Glioblastoma, Gliosarcoma

Astrocytoma, Glioblastoma

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

Glioblastoma, Glioma

Glioblastoma

Glioblastoma

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma

Glioblastoma, Gliosarcoma

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Glioblastoma, Gliosarcoma

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Brain Neoplasms, Glioblastoma, Leukemia, Sarcoma

Glioblastoma, Gliosarcoma

Glioblastoma, Gliosarcoma

Glioblastoma, Gliosarcoma

Brain Neoplasms, Glioblastoma

Glioblastoma, Gliosarcoma

Brain Neoplasms, Glioblastoma, Glioma, Neoplasms

Astrocytoma, Glioblastoma, Glioma, Medulloblastoma, Neoplasms, Oligodendroglioma, Central Nervous System Neoplasms

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Neuroectodermal Tumors, Primitive

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Neoplasms, Oligodendroglioma, Recurrence

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma

Brain Neoplasms, Glioblastoma, Gliosarcoma

Glioblastoma, Gliosarcoma

Glioblastoma, Gliosarcoma

Brain Neoplasms, Glioblastoma, Gliosarcoma

Glioblastoma, Glioma

Brain Neoplasms, Glioblastoma, Glioma, Neoplasms, Gliosarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma

Brain Neoplasms, Glioblastoma, Gliosarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma

Glioblastoma, Gliosarcoma

Brain Neoplasms, Depression, Glioblastoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Gliosarcoma

Clinical Trials

Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas

Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma

A Study Testing the Effect of Immunotherapy (Ipilimumab and Nivolumab) in Patients With Recurrent Glioma With Elevated Mutational Burden

Association of Peripheral Blood Immunologic Response to Therapeutic Response to Adjuvant Treatment With Immune Checkpoint Inhibition (ICI) in Patients With Newly Diagnosed Glioblastoma or Gliosarcoma

Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment

Anti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma

Testing the Combination of Anti-cancer Drugs Actimab-A and Cemiplimab (REGN2810) to Improve Outcomes for Patients With Recurrent Glioblastoma

PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications

Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma

Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma

Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations

Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma

Collection of Blood and Urine Samples in Patients Receiving Radiation Therapy for Glioblastoma Multiforme

Dose Escalation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma

TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors

Testing the Ability of AMG 232 (KRT 232) to Get Into the Tumor in Patients With Brain Cancer

Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma

Oral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) Without Prior Bevacizumab Exposure and (B) After Failing Prior Bevacizumab

Radiation Therapy Plus Temozolomide and Pembrolizumab With and Without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM)

Adavosertib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma

Testing the Combination of Anti-cancer Drugs Tiragolumab and Atezolizumab to Improve Outcomes for Patients With Recurrent Glioblastoma

Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma

Sapanisertib Before and After Surgery in Treating Patients With Recurrent Glioblastoma

Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas

Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children and Young Adults With High Grade or High-Risk Cancer and Their Caregivers

Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

Vorinostat, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma

Phase I-II Everolimus and Sorafenib in Recurrent High-Grade Gliomas

Gefitinib and Radiation Therapy in Treating Patients With Glioblastoma Multiforme

AZD7451 for Recurrent Gliomas

Natural History of Patients With Brain and Spinal Cord Tumors

A Pilot Study Evaluating 18F-L-Thymidine (FLT) PET Imaging in Children With Gliomas

AZD8055 for Adults With Recurrent Gliomas

Genetic Analysis of Brain Tumors

Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma

Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma

MRI and PET/FMISO In Assessing Tumor Hypoxia in Patients With Newly Diagnosed Glioblastoma Multiforme

Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma

Phase I/II Adaptive Randomized Trial of Bevacizumab Versus Bevacizumab Plus Vorinostat in Adults With Recurrent Glioblastoma

GW572016 to Treat Recurrent Malignant Brain Tumors

(11C)dLop as a Marker of P-Glycoprotein Function in Patients With Gliomas

Sorafenib Combined With Erlotinib, Tipifarnib, or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma

Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme

Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

Magnetic Resonance Spectroscopy Imaging in Predicting Response to Vorinostat and Temozolomide in Patients With Recurrent or Progressive Glioblastoma

A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade Gliomas